300 related articles for article (PubMed ID: 36549296)
21. Does aerobic exercise reduce NASH and liver fibrosis in patients with non-alcoholic fatty liver disease? A systematic literature review and meta-analysis.
Houttu V; Bouts J; Vali Y; Daams J; Grefhorst A; Nieuwdorp M; Holleboom AG
Front Endocrinol (Lausanne); 2022; 13():1032164. PubMed ID: 36407307
[TBL] [Abstract][Full Text] [Related]
22. Positive Effects of Exercise Intervention without Weight Loss and Dietary Changes in NAFLD-Related Clinical Parameters: A Systematic Review and Meta-Analysis.
Babu AF; Csader S; Lok J; Gómez-Gallego C; Hanhineva K; El-Nezami H; Schwab U
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579012
[TBL] [Abstract][Full Text] [Related]
23. Long-term effect of exercise on improving fatty liver and cardiovascular risk factors in obese adults: A 1-year follow-up study.
Zhang HJ; Pan LL; Ma ZM; Chen Z; Huang ZF; Sun Q; Lu Y; Han CK; Lin MZ; Li XJ; Yang SY; Li XY
Diabetes Obes Metab; 2017 Feb; 19(2):284-289. PubMed ID: 27761987
[TBL] [Abstract][Full Text] [Related]
24. Effects of Time-Restricted Eating on Nonalcoholic Fatty Liver Disease: The TREATY-FLD Randomized Clinical Trial.
Wei X; Lin B; Huang Y; Yang S; Huang C; Shi L; Liu D; Zhang P; Lin J; Xu B; Guo D; Li C; He H; Liu S; Xue Y; Xu Y; Zhang H
JAMA Netw Open; 2023 Mar; 6(3):e233513. PubMed ID: 36930148
[TBL] [Abstract][Full Text] [Related]
25. Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial.
Winn NC; Liu Y; Rector RS; Parks EJ; Ibdah JA; Kanaley JA
Metabolism; 2018 Jan; 78():128-140. PubMed ID: 28941598
[TBL] [Abstract][Full Text] [Related]
26. Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial.
Guo W; Tian W; Lin L; Xu X
Diabetes Res Clin Pract; 2020 Dec; 170():108487. PubMed ID: 33035599
[TBL] [Abstract][Full Text] [Related]
27. Effect of Aerobic Exercise Alone or in Conjunction With Diet on Liver Function, Insulin Resistance and Lipids in Non-Alcoholic Fatty Liver Disease.
Mohammad Rahimi GR; Attarzadeh Hosseini SR
Biol Res Nurs; 2022 Apr; 24(2):259-276. PubMed ID: 35130757
[TBL] [Abstract][Full Text] [Related]
28. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
[TBL] [Abstract][Full Text] [Related]
29. Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease.
Malin SK; Mulya A; Fealy CE; Haus JM; Pagadala MR; Scelsi AR; Huang H; Flask CA; McCullough AJ; Kirwan JP
J Appl Physiol (1985); 2013 Oct; 115(7):988-94. PubMed ID: 23928114
[TBL] [Abstract][Full Text] [Related]
30. A randomized controlled trial on the effectiveness of 8-week high-intensity interval exercise on intrahepatic triglycerides, visceral lipids, and health-related quality of life in diabetic obese patients with nonalcoholic fatty liver disease.
Abdelbasset WK; Tantawy SA; Kamel DM; Alqahtani BA; Soliman GS
Medicine (Baltimore); 2019 Mar; 98(12):e14918. PubMed ID: 30896648
[TBL] [Abstract][Full Text] [Related]
31. Effects of high-intensity interval and moderate-intensity continuous aerobic exercise on diabetic obese patients with nonalcoholic fatty liver disease: A comparative randomized controlled trial.
Abdelbasset WK; Tantawy SA; Kamel DM; Alqahtani BA; Elnegamy TE; Soliman GS; Ibrahim AA
Medicine (Baltimore); 2020 Mar; 99(10):e19471. PubMed ID: 32150108
[TBL] [Abstract][Full Text] [Related]
32. Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPARα/Fgf21 signaling.
Liu X; Zhang Y; Ma C; Lin J; Du J
Mol Biol Rep; 2022 Apr; 49(4):3113-3122. PubMed ID: 35107741
[TBL] [Abstract][Full Text] [Related]
33. Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trial.
Lorvand Amiri H; Agah S; Tolouei Azar J; Hosseini S; Shidfar F; Mousavi SN
Clin Nutr; 2017 Dec; 36(6):1490-1497. PubMed ID: 27720403
[TBL] [Abstract][Full Text] [Related]
34. [TEN-HOUR INTERMITTENT FASTING PLUS MEDITERRANEAN DIET VERSUS MEDITERRANEAN DIET ALONE FOR TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)].
Milgrom Y; Massarwa M; Hazou W; Shafrir A; Mishraki E; Sanduka S; Safadi R; Benson A
Harefuah; 2024 Feb; 163(2):93-96. PubMed ID: 38431857
[TBL] [Abstract][Full Text] [Related]
35. Alternate day fasting combined with a low-carbohydrate diet for weight loss, weight maintenance, and metabolic disease risk reduction.
Kalam F; Gabel K; Cienfuegos S; Wiseman E; Ezpeleta M; Steward M; Pavlou V; Varady KA
Obes Sci Pract; 2019 Dec; 5(6):531-539. PubMed ID: 31890243
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of nanocurcumin supplementation on insulin resistance, lipids, inflammatory factors and nesfatin among obese patients with non-alcoholic fatty liver disease (NAFLD): a trial protocol.
Jazayeri-Tehrani SA; Rezayat SM; Mansouri S; Qorbani M; Alavian SM; Daneshi-Maskooni M; Hosseinzadeh-Attar MJ
BMJ Open; 2017 Jul; 7(7):e016914. PubMed ID: 28698350
[TBL] [Abstract][Full Text] [Related]
37. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial.
Cheng S; Ge J; Zhao C; Le S; Yang Y; Ke D; Wu N; Tan X; Zhang X; Du X; Sun J; Wang R; Shi Y; Borra RJH; Parkkola R; Wiklund P; Lu D
Sci Rep; 2017 Nov; 7(1):15952. PubMed ID: 29162875
[TBL] [Abstract][Full Text] [Related]
38. Does the weight loss efficacy of alternate day fasting differ according to sex and menopausal status?
Lin S; Lima Oliveira M; Gabel K; Kalam F; Cienfuegos S; Ezpeleta M; Bhutani S; Varady KA
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):641-649. PubMed ID: 33358713
[TBL] [Abstract][Full Text] [Related]
39. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials.
Guo XF; Yang B; Tang J; Li D
Clin Nutr; 2018 Feb; 37(1):113-122. PubMed ID: 28161092
[TBL] [Abstract][Full Text] [Related]
40. Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease.
Maruszczak K; Radzikowski K; Schütz S; Mangge H; Bergsten P; Forslund A; Manell H; Pixner T; Ahlström H; Kullberg J; Mörwald K; Weghuber D
Front Endocrinol (Lausanne); 2022; 13():1004128. PubMed ID: 36133310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
